• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉内化疗:成人视网膜母细胞瘤治疗的新希望——一例报告及简要综述

Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review.

作者信息

Riazi-Esfahani Hamid, Masoomian Babak, Ghassemi Fariba

机构信息

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Ocular Oncology Department, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Case Rep Ophthalmol Med. 2021 Jul 9;2021:6639900. doi: 10.1155/2021/6639900. eCollection 2021.

DOI:10.1155/2021/6639900
PMID:34336323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8289600/
Abstract

BACKGROUND

Adult retinoblastoma (RB) is a rare intraocular tumor, leading to delayed diagnosis and, eventually, enucleation of the involved eyes. Therefore, this diagnosis should be considered if attributable signs and symptoms occurred. Here, the authors report a case of an adult group D RB, treated successfully with intra-arterial chemotherapy (IAC) as primary treatment followed by cryotherapy. The authors briefly review the literature on the prognosis and management of adult RB. . A 22-year-old man has noticed floaters in his right eye for 2 months. Right eye examination revealed diffuse white spherical calcified vitreous seeds in all quadrants and a large white endophytic mass in the superonasal quadrant with engorged feeding vessels. Based on clinical data, the group D RB tumor was classified and the IAC was started with 2 medications, melphalan (5 mg) and topotecan (1 mg), for 3 cycles. Trans-scleral triple freeze-thaw cryotherapy was used as an adjunctive treatment at the latest hospital visit. Thirteen months after the last treatment, the RB tumor showed type 4 regression (flat chorioretinal scar) and no evidence of recurrence was identified.

CONCLUSION

It seems that IAC, as the first line of treatment, either alone or in conjunction with adjuvant therapies may allow us to salvage the globe of adult patients involved with RB.

摘要

背景

成人视网膜母细胞瘤(RB)是一种罕见的眼内肿瘤,常导致诊断延迟,最终患眼被摘除。因此,出现相关体征和症状时应考虑这一诊断。在此,作者报告一例成人D组RB病例,该病例以动脉内化疗(IAC)作为主要治疗方法,随后进行冷冻疗法,治疗成功。作者简要回顾了关于成人RB预后和治疗的文献。一名22岁男性右眼出现飞蚊症2个月。右眼检查发现所有象限均有弥漫性白色球形钙化玻璃体种子,鼻上象限有一个大的白色内生性肿块,供血血管迂曲。根据临床资料,对D组RB肿瘤进行分类,并开始使用美法仑(5毫克)和拓扑替康(1毫克)两种药物进行3个周期的IAC治疗。在最近一次就诊时,采用经巩膜三次冻融冷冻疗法作为辅助治疗。最后一次治疗13个月后,RB肿瘤显示为4型消退(扁平脉络膜视网膜瘢痕),未发现复发迹象。

结论

IAC作为一线治疗方法,单独使用或与辅助治疗联合使用,似乎可以使我们挽救患有RB的成年患者的眼球。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd6/8289600/2feb46b479ab/CRIOPM2021-6639900.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd6/8289600/632e9cdf583b/CRIOPM2021-6639900.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd6/8289600/2feb46b479ab/CRIOPM2021-6639900.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd6/8289600/632e9cdf583b/CRIOPM2021-6639900.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd6/8289600/2feb46b479ab/CRIOPM2021-6639900.002.jpg

相似文献

1
Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review.动脉内化疗:成人视网膜母细胞瘤治疗的新希望——一例报告及简要综述
Case Rep Ophthalmol Med. 2021 Jul 9;2021:6639900. doi: 10.1155/2021/6639900. eCollection 2021.
2
Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.初始动脉内化疗后视网膜母细胞瘤复发后的挽救性动脉内化疗。
J Fr Ophtalmol. 2015 Jun;38(6):542-9. doi: 10.1016/j.jfo.2015.03.004. Epub 2015 May 14.
3
Intra-arterial chemotherapy for retinoblastoma: First Indian report.视网膜母细胞瘤的动脉内化疗:印度首份报告。
Indian J Ophthalmol. 2015 Apr;63(4):331-4. doi: 10.4103/0301-4738.158076.
4
Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.眼内动脉化疗治疗视网膜母细胞瘤的最小暴露(一至两个周期)。
Ophthalmology. 2012 Jan;119(1):188-92. doi: 10.1016/j.ophtha.2011.06.036. Epub 2011 Oct 5.
5
Single- Versus Triple-Agent Intra-Arterial Chemotherapy for Retinoblastoma.视网膜母细胞瘤的单药与三联动脉内化疗
Am J Ophthalmol. 2025 Jan;269:488-496. doi: 10.1016/j.ajo.2024.09.037. Epub 2024 Oct 10.
6
Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.视网膜母细胞瘤的动脉内化疗:来自印度三级眼科护理中心的两年结果。
Indian J Ophthalmol. 2017 Apr;65(4):311-315. doi: 10.4103/ijo.IJO_843_16.
7
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.大龄儿童(>5 岁)视网膜母细胞瘤的经动脉化疗治疗:与化疗前和静脉化疗时代的结局比较。
Indian J Ophthalmol. 2019 Dec;67(12):2005-2011. doi: 10.4103/ijo.IJO_642_19.
8
Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience.玻璃体内化疗时代视网膜母细胞瘤的原发性动脉内化疗:五年经验
Ocul Oncol Pathol. 2019 Feb;5(2):139-146. doi: 10.1159/000491580. Epub 2018 Aug 21.
9
Five-Year Experience in Treatment of Retinoblastoma with Intra-Arterial Chemotherapy: A Single-Center Analysis.动脉内化疗治疗视网膜母细胞瘤的五年经验:单中心分析
J Curr Ophthalmol. 2022 Jan 6;33(4):468-474. doi: 10.4103/joco.joco_113_21. eCollection 2021 Oct-Dec.
10
Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India.视网膜母细胞瘤的动脉内化疗:来自印度三级中心的四年结果
Ocul Oncol Pathol. 2020 Jan;6(1):66-73. doi: 10.1159/000500010. Epub 2019 Jun 4.

本文引用的文献

1
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.大龄儿童(>5 岁)视网膜母细胞瘤的经动脉化疗治疗:与化疗前和静脉化疗时代的结局比较。
Indian J Ophthalmol. 2019 Dec;67(12):2005-2011. doi: 10.4103/ijo.IJO_642_19.
2
Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age.老年患者的视网膜母细胞瘤:基于年龄对100例连续患者的回顾性比较分析。
Saudi J Ophthalmol. 2019 Jul-Sep;33(3):243-250. doi: 10.1016/j.sjopt.2019.07.008. Epub 2019 Aug 27.
3
Retinoblastoma in a 23-year-old adult treated with primary intra-arterial and intravitreal chemotherapy.
一名23岁成年人视网膜母细胞瘤接受动脉内和玻璃体内化疗的原发性治疗。
Oman J Ophthalmol. 2019 May-Aug;12(2):119-121. doi: 10.4103/ojo.OJO_162_2018.
4
Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.静脉化疗与眼内动脉化疗治疗视网膜母细胞瘤的比较:一项荟萃分析。
BMC Cancer. 2018 Apr 27;18(1):486. doi: 10.1186/s12885-018-4406-6.
5
Retinoblastoma.视网膜母细胞瘤。
Indian J Pediatr. 2017 Dec;84(12):937-944. doi: 10.1007/s12098-017-2395-0. Epub 2017 Jun 16.
6
Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.全身化疗减积联合局部治疗视网膜母细胞瘤的临床结局及消退模式:一项前瞻性研究。
Indian J Ophthalmol. 2016 Jul;64(7):524-9. doi: 10.4103/0301-4738.190143.
7
Adult onset retinoblastoma.成人型视网膜母细胞瘤
Indian J Ophthalmol. 2016 Jul;64(7):485-91. doi: 10.4103/0301-4738.190099.
8
Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
J Pediatr Ophthalmol Strabismus. 2016 Jul 30;53:e43-6. doi: 10.3928/01913913-20160722-01.
9
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.晚期单侧视网膜母细胞瘤:眼动脉化疗手术对MSKCC眼球摘除率和患者生存率的影响
PLoS One. 2015 Dec 28;10(12):e0145436. doi: 10.1371/journal.pone.0145436. eCollection 2015.
10
NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS.成人新诊断的活动性视网膜母细胞瘤
Retina. 2015 Dec;35(12):2483-8. doi: 10.1097/IAE.0000000000000612.